Oncology PracticeFDA proposal encourages development of abuse deterrent opioidsJanuary 10, 2013Genitourinary CancerPatient & Survivor Care
Oncology PracticeFDA approves abiraterone use ahead of prostate cancer chemotherapy December 12, 2012Genitourinary Cancer
Oncology PracticeMedicare policy change led to higher drug spendingDecember 5, 2012Practice ManagementGenitourinary CancerBusiness of Medicine
Oncology PracticePsoriasis Patients Have Low Rates of Common CancersNovember 30, 2012Breast CancerGastroenterologyGenitourinary CancerGastrointestinal Cancer
Oncology PracticeThe Long and the Short of Bladder Cancer SurvivalNovember 12, 2012Genitourinary Cancer
Oncology PracticeSildenafil Protects Sexual Function Following Prostate RadiationNovember 8, 2012Genitourinary Cancer
Oncology PracticeInoperable Kidney Cancer Responds to Stereotactic Radiosurgery November 7, 2012Genitourinary Cancer
Oncology PracticeTuberous Sclerosis Skin Lesions Improved on EverolimusNovember 2, 2012MelanomaRare DiseasesGenitourinary Cancer
Oncology PracticeRadiation Plus Hormonal Therapy Boosts Prostate Cancer SurvivalOctober 31, 2012Genitourinary Cancer
Oncology PracticeOnly Short-Term Advantage for Protons in Prostate CancerOctober 29, 2012Genitourinary Cancer
Oncology PracticeTrastuzumab Role May Be Limited in HER2-Positive Bladder CancerOctober 25, 2012Genitourinary Cancer
Oncology PracticemTOR Inhibitors Tank in Three Advanced Kidney Cancer TrialsOctober 24, 2012Genitourinary Cancer
Oncology PracticePostop Radiation Slows Prostate Cancer ProgressionOctober 24, 2012Genitourinary Cancer
Oncology PracticeThe Cancer Screening WarsOctober 22, 2012Breast CancerGenitourinary CancerLung CancerPreventive Care
Oncology PracticeEverolimus With or Without Bevacizumab in Patients With Advanced Kidney Cancer That Progressed After First-Line TherapyOctober 16, 2012Genitourinary Cancer
